Company Profile of Zhejiang Changming Pharmaceutical Co., Ltd.

Zhejiang Changming Pharmaceutical Co., Ltd. is a high-tech enterprise integrating R & D, production and sales of pharmaceutical raw materials and intermediates under the Zhejiang Shengda Group. The company's leading products are enalapril, ramipril, lisinopril and other ACE inhibitor series APIs and intermediates. The products are mainly sold to Southeast Asia, Europe, America and other countries and regions. The company's address is located in Tiantai County Industrial Park, Taizhou City, Zhejiang Province. It covers an area of 98 acres and has total assets of 160 million yuan. It has more than 280 employees, including more than 80 senior technical and management personnel. The company has built a modern factory building that meets GMP standards, and has successively passed China GMP certification, ISO9001: 2008 quality management system certification, ISO14001: 2004 environmental management system certification and OHSAS18000-2001 occupational health and safety management system certification. The company's leading products enalapril maleate, ramipril, lisinopril have obtained the EU COS certificate and passed the US FDA review and EU official review.